{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:26:09Z","timestamp":1792207569764,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7614","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,8,4]]},"DOI":"10.1038\/nature18935","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T10:55:44Z","timestamp":1468925744000},"page":"86-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":671,"title":["CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis"],"prefix":"10.1038","volume":"536","author":[{"given":"Yoko","family":"Kojima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Volkmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mete","family":"Civelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldons Jake","family":"Lusis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Direnzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Schadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Quertermous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Betancur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Maegdefessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica Perisic","family":"Matic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Hedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving L.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Leeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"key":"BFnature18935_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby, P., Ridker, P. M. & Hansson, G. K. Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317\u2013325 (2011)","journal-title":"Nature"},{"key":"BFnature18935_CR2","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","volume":"25","author":"DM Schrijvers","year":"2005","unstructured":"Schrijvers, D. M., De Meyer, G. R., Kockx, M. M., Herman, A. G. & Martinet, W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 1256\u20131261 (2005)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnature18935_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1189\/jlb.0209115","volume":"86","author":"E Thorp","year":"2009","unstructured":"Thorp, E. & Tabas, I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J. Leukoc. Biol. 86, 1089\u20131095 (2009)","journal-title":"J. Leukoc. Biol."},{"key":"BFnature18935_CR4","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","volume":"288","author":"PA Oldenborg","year":"2000","unstructured":"Oldenborg, P. A. et al. Role of CD47 as a marker of self on red blood cells. Science 288, 2051\u20132054 (2000)","journal-title":"Science"},{"key":"BFnature18935_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrc3171","volume":"12","author":"MP Chao","year":"2011","unstructured":"Chao, M. P., Majeti, R. & Weissman, I. L. Programmed cell removal: a new obstacle in the road to developing cancer. Nat. Rev. Cancer 12, 58\u201367 (2011)","journal-title":"Nat. Rev. Cancer"},{"key":"BFnature18935_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","volume":"123","author":"SJ Gardai","year":"2005","unstructured":"Gardai, S. J. et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321\u2013334 (2005)","journal-title":"Cell"},{"key":"BFnature18935_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti, R. et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138, 286\u2013299 (2009)","journal-title":"Cell"},{"key":"BFnature18935_CR8","doi-asserted-by":"publisher","first-page":"R521","DOI":"10.1016\/j.cub.2008.04.058","volume":"18","author":"JM Kinchen","year":"2008","unstructured":"Kinchen, J. M. & Ravichandran, K. S. Phagocytic signaling: you can touch, but you can\u2019t eat. Curr. Biol. 18, R521\u2013R524 (2008)","journal-title":"Curr. Biol."},{"key":"BFnature18935_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-\u03b2, PGE2, and PAF. J. Clin. Invest. 101, 890\u2013898 (1998)","journal-title":"J. Clin. Invest."},{"key":"BFnature18935_CR10","doi-asserted-by":"publisher","first-page":"R795","DOI":"10.1016\/S0960-9822(01)00474-2","volume":"11","author":"PM Henson","year":"2001","unstructured":"Henson, P. M., Bratton, D. L. & Fadok, V. A. Apoptotic cell removal. Curr. Biol. 11, R795\u2013R805 (2001)","journal-title":"Curr. Biol."},{"key":"BFnature18935_CR11","unstructured":"World Health Organization. The top ten causes of death. http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/ (2014)"},{"key":"BFnature18935_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nm.3866","volume":"21","author":"LS Shankman","year":"2015","unstructured":"Shankman, L. S. et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat. Med. 21, 628\u2013637 (2015)","journal-title":"Nat. Med."},{"key":"BFnature18935_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri2675","volume":"10","author":"I Tabas","year":"2010","unstructured":"Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36\u201346 (2010)","journal-title":"Nat. Rev. Immunol."},{"key":"BFnature18935_CR14","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/ATVBAHA.108.167197","volume":"28","author":"E Thorp","year":"2008","unstructured":"Thorp, E., Cui, D., Schrijvers, D. M., Kuriakose, G. & Tabas, I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe\u2212\/\u2212 mice. Arterioscler. Thromb. Vasc. Biol. 28, 1421\u20131428 (2008)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnature18935_CR15","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2012","unstructured":"Willingham, S. B. et al. The CD47-signal regulatory protein alpha (SIRP\u03b1) interaction is a therapeutic target for human solid tumors. Proc. Natl Acad. Sci. USA 109, 6662\u20136667 (2012)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature18935_CR16","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1161\/ATVBAHA.113.301743","volume":"33","author":"L Perisic","year":"2013","unstructured":"Perisic, L. et al. Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 33, 2432\u20132443 (2013)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnature18935_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1172\/JCI70391","volume":"124","author":"Y Kojima","year":"2014","unstructured":"Kojima, Y. et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J. Clin. Invest. 124, 1083\u20131097 (2014)","journal-title":"J. Clin. Invest."},{"key":"BFnature18935_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/cvr\/cvs301","volume":"97","author":"U Garbin","year":"2013","unstructured":"Garbin, U. et al. Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids? Cardiovasc. Res. 97, 125\u2013133 (2013)","journal-title":"Cardiovasc. Res."},{"key":"BFnature18935_CR19","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A Daugherty","year":"2000","unstructured":"Daugherty, A., Manning, M. W. & Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105, 1605\u20131612 (2000)","journal-title":"J. Clin. Invest."},{"key":"BFnature18935_CR20","doi-asserted-by":"publisher","first-page":"26069","DOI":"10.1074\/jbc.M605040200","volume":"281","author":"JS Isenberg","year":"2006","unstructured":"Isenberg, J. S. et al. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J. Biol. Chem. 281, 26069\u201326080 (2006)","journal-title":"J. Biol. Chem."},{"key":"BFnature18935_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","volume":"12","author":"M B\u00e4ck","year":"2015","unstructured":"B\u00e4ck, M. & Hansson, G. K. Anti-inflammatory therapies for atherosclerosis. Nat. Rev. Cardiol. 12, 199\u2013211 (2015)","journal-title":"Nat. Rev. Cardiol."},{"key":"BFnature18935_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1152\/physrev.00004.2012","volume":"93","author":"PN Hopkins","year":"2013","unstructured":"Hopkins, P. N. Molecular biology of atherosclerosis. Physiol. Rev. 93, 1317\u20131542 (2013)","journal-title":"Physiol. Rev."},{"key":"BFnature18935_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2011.168","volume":"8","author":"JD Greenberg","year":"2011","unstructured":"Greenberg, J. D., Furer, V. & Farkouh, M. E. Cardiovascular safety of biologic therapies for the treatment of RA. Nat. Rev. Rheumatol. 8, 13\u201321 (2011)","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnature18935_CR24","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1073\/pnas.1222861110","volume":"110","author":"WW Pang","year":"2013","unstructured":"Pang, W. W. et al. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc. Natl Acad. Sci. USA 110, 3011\u20133016 (2013)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature18935_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","volume":"115","author":"S Feil","year":"2014","unstructured":"Feil, S. et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ. Res. 115, 662\u2013667 (2014)","journal-title":"Circ. Res."},{"key":"BFnature18935_CR26","first-page":"913","volume":"152","author":"IM Chung","year":"1998","unstructured":"Chung, I. M., Schwartz, S. M. & Murry, C. E. Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. Am. J. Pathol. 152, 913\u2013923 (1998)","journal-title":"Am. J. Pathol."},{"key":"BFnature18935_CR27","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1126\/science.1142447","volume":"316","author":"R McPherson","year":"2007","unstructured":"McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488\u20131491 (2007)","journal-title":"Science"},{"key":"BFnature18935_CR28","doi-asserted-by":"publisher","first-page":"e0137345","DOI":"10.1371\/journal.pone.0137345","volume":"10","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential. PLoS One 10, e0137345 (2015)","journal-title":"PLoS One"},{"key":"BFnature18935_CR29","unstructured":"ClinicalTrials.gov: NCT02216409"},{"key":"BFnature18935_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby, P. Inflammation in atherosclerosis. Nature 420, 868\u2013874 (2002)","journal-title":"Nature"},{"key":"BFnature18935_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00109-011-0773-z","volume":"89","author":"J Saksi","year":"2011","unstructured":"Saksi, J. et al. Gene expression differences between stroke-associated and asymptomatic carotid plaques. J. Mol. Med. (Berl.) 89, 1015\u20131026 (2011)","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnature18935_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physiolgenomics.00101.2005","volume":"23","author":"JY King","year":"2005","unstructured":"King, J. Y. et al. Pathway analysis of coronary atherosclerosis. Physiol. Genomics 23, 103\u2013118 (2005)","journal-title":"Physiol. Genomics"},{"key":"BFnature18935_CR33","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1161\/CIRCULATIONAHA.106.637025","volume":"114","author":"EA Ashley","year":"2006","unstructured":"Ashley, E. A. et al. Network analysis of human in-stent restenosis. Circulation 114, 2644\u20132654 (2006)","journal-title":"Circulation"},{"key":"BFnature18935_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/joim.12448","volume":"279","author":"L Perisic","year":"2016","unstructured":"Perisic, L. et al. Gene expression signatures, pathways and networks in carotid atherosclerosis. J. Intern. Med. 279, 293\u2013308 (2016)","journal-title":"J. Intern. Med."},{"key":"BFnature18935_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/CIRCRESAHA.113.301562","volume":"113","author":"YC Chen","year":"2013","unstructured":"Chen, Y. C. et al. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic\/therapeutic discoveries using gene and microRNA expression profiling. Circ. Res. 113, 252\u2013265 (2013)","journal-title":"Circ. Res."},{"key":"BFnature18935_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2009.10.017","volume":"209","author":"J Jun","year":"2010","unstructured":"Jun, J. et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 209, 381\u2013386 (2010)","journal-title":"Atherosclerosis"},{"key":"BFnature18935_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1172\/JCI43713","volume":"122","author":"MR Alexander","year":"2012","unstructured":"Alexander, M. R. et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J. Clin. Invest. 122, 70\u201379 (2012)","journal-title":"J. Clin. Invest."},{"key":"BFnature18935_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nmeth.1359","volume":"6","author":"H Yang","year":"2009","unstructured":"Yang, H. et al. A customized and versatile high-density genotyping array for the mouse. Nat. Methods 6, 663\u2013666 (2009)","journal-title":"Nat. Methods"},{"key":"BFnature18935_CR39","doi-asserted-by":"publisher","first-page":"e1001393","DOI":"10.1371\/journal.pgen.1001393","volume":"7","author":"A Ghazalpour","year":"2011","unstructured":"Ghazalpour, A. et al. Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet. 7, e1001393 (2011)","journal-title":"PLoS Genet."},{"key":"BFnature18935_CR40","doi-asserted-by":"publisher","first-page":"13531","DOI":"10.1073\/pnas.1735526100","volume":"100","author":"JX Rong","year":"2003","unstructured":"Rong, J. X., Shapiro, M., Trogan, E. & Fisher, E. A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl Acad. Sci. USA 100, 13531\u201313536 (2003)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature18935_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1238856","volume":"341","author":"K Weiskopf","year":"2013","unstructured":"Weiskopf, K. et al. Engineered SIRP\u03b1 variants as immunotherapeutic adjuvants to anticancer antibodies. Science 341, 88\u201391 (2013)","journal-title":"Science"},{"key":"BFnature18935_CR42","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/ATVBAHA.112.300399","volume":"33","author":"NJ Leeper","year":"2013","unstructured":"Leeper, N. J. et al. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 33, e1\u2013e10 (2013)","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature18935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature18935","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature18935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T16:07:45Z","timestamp":1630685265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature18935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":42,"journal-issue":{"issue":"7614","published-print":{"date-parts":[[2016,8,4]]}},"alternative-id":["BFnature18935"],"URL":"https:\/\/doi.org\/10.1038\/nature18935","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726563155.793563065","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]},"assertion":[{"value":"8 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.J.L. and I.L.W. have filed a patent describing inhibition of CD47 as a method of preventing atherosclerosis. This patent has been licensed by Forty Seven Inc. N.J.L., J.P.V. and I.L.W. declare equity ownership in Forty Seven Inc. I.L.W. is a Director of Forty Seven, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}